Engineered plants may make baby formula more like breast milk

New research shows how genetically engineered plants may help make baby formula as nutritious as breast milk.

Worldwide, a majority of babies—approximately 75%—drink infant formula in their first six months of life, either as a sole source of nutrition or as a supplement to breastfeeding. But while formula provides essential food for growing babies, it currently does not replicate the full nutritional profile of breast milk.

That’s in part because human breast milk contains a unique blend of approximately 200 prebiotic sugar molecules that help prevent disease and support the growth of healthy gut bacteria. However, most of these sugars remain difficult, if not impossible, to manufacture.

In the new study in the journal Nature Food, the researchers reprogrammed plants’ sugar-making machinery to produce a diverse array of these human milk sugars, also called human milk oligosaccharides.

The findings could lead to healthier and more affordable formula for babies, or more nutritious non-dairy plant milk for adults.

“Plants are these phenomenal organisms that take sunlight and carbon dioxide from our atmosphere and use them to make sugars. And they don’t just make one sugar—they make a whole diversity of simple and complex sugars,” says study senior author Patrick Shih, an assistant professor of plant and microbial biology and an investigator at the University of California, Berkeley’s Innovative Genomics Institute.

“We thought, since plants already have this underlying sugar metabolism, why don’t we try rerouting it to make human milk oligosaccharides?”

All complex sugars—including human milk oligosaccharides—are made from building blocks of simple sugars, called monosaccharides, which can be linked together to form a vast array of chains and branched chains. What makes human milk oligosaccharides unique are the specific set of linkages, or rules, for connecting simple sugars together that are found in these molecules.

To convince plants to make human milk oligosaccharides, first author Collin Barnum engineered the genes responsible for the enzymes that make these specific linkages. Working with Daniela Barile, David Mills, and Carlito Lebrilla at UC Davis, he then introduced the genes into the Nicotiana benthamiana plant, a close relative of tobacco.

The genetically modified plants produced 11 known human milk oligosaccharides, along with a variety of other complex sugars with similar linkage patterns.

“We made all three major groups of human milk oligosaccharides,” Shih says. “To my knowledge, no one has ever demonstrated that you could make all three of these groups simultaneously in a single organism.”

Barnum then worked to create a stable line of N. benthamiana plants that were optimized to produce a single human milk oligosaccharide called LNFP1.

“LNFP1 is a five-monosaccharide-long human milk oligosaccharide that is supposed to be really beneficial, but so far cannot be made at scale using traditional methods of microbial fermentation,” says Barnum, who completed the work as a graduate student at UC Davis.

“We thought that if we could start making these larger, more complex human milk oligosaccharides, we could solve a problem that that industry currently can’t solve.”

Currently, a small handful of human milk oligosaccharides can be manufactured using engineered E. coli bacteria. However, isolating the beneficial molecules from other toxic byproducts is a costly process, and only a limited number of baby formulas include these sugars in their mixtures.

As part of the study, Shih and Barnum worked with collaborator Minliang Yang at North Carolina State University to estimate the cost of producing human milk oligosaccharides from plants at an industrial scale and found that it would likely be cheaper than using microbial platforms.

“Imagine being able to make all the human milk oligosaccharides in a single plant. Then you could just grind up that plant, extract all the oligosaccharides simultaneously, and add that directly into infant formula,” Shih says.

“There would be a lot of challenges in implementation and commercialization, but this is the big goal that we’re trying to move toward.”

Additional authors are from UC Davis, UC Berkeley, and North Carolina State University.

Support for the work came in part from the National Institutes of Health, the US Department of Energy, and the National Center for Complementary and Integrative Health.

Source: UC Berkeley